Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PAR PHARMACEUTICAL COS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 263.73 M 285.51 M 213.11 M 196.54 M 188.39 M
    Net Receivables 118.80 M 81.70 M 107.21 M 81.22 M 149.11 M
    Total Inventories 42.50 M 84.89 M 106.32 M 96.39 M 86.84 M
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses 15.83 M 18.76 M — — —
    Other Current Assets 75.27 M 71.22 M 72.10 M 71.20 M 69.72 M
    Current Assets Total 500.30 M 523.31 M 514.58 M 464.12 M 493.98 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 6.31 M 5.29 M 4.15 M 0.00
    Other Investments 1.95 M 9.19 M 24.24 M 25.48 M 25.27 M
    Property, Plant & Equipment Net 79.44 M 82.65 M 89.16 M 87.57 M 66.64 M
    Property, Plant & Equipment Gross 133.44 M 134.67 M 137.10 M 125.89 M 98.95 M
    Accumulated Depreciation 54.00 M 52.02 M 47.95 M 38.32 M 32.31 M
    Other Assets 100.10 M 102.33 M 127.61 M 103.79 M 111.33 M
    Deferred Charges 1.16 M 2.54 M 16.00 M 8.83 M 11.23 M
    Tangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Intangible Other Assets 98.94 M 99.79 M 111.61 M 94.96 M 129.41 M
    Total Assets 681.79 M 723.79 M 760.87 M 685.11 M 726.54 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 142.00 M 200.00 M 204.47 M 3.01 M 4.35 M
    Accrued Payroll 11.85 M 16.60 M 15.51 M 12.78 M 8.74 M
    Income Taxes Payable 16.97 M 9.68 M 39.12 M 26.25 M 26.07 M
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 129.80 M 64.00 M 104.16 M 74.62 M 55.96 M
    Current Liabilities Total 306.53 M 312.79 M 389.41 M 156.51 M 154.74 M
    Long Term Debt 0.00 0.00 0.00 202.00 M 200.28 M
    Provision for Risks & Charges 0.00 0.00 0.00 — —
    Deferred Taxes -70.95 M -57.73 M -49.54 M -50.92 M -42.46 M
    Deferred Income 0.00 0.00 0.00 — —
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 41.58 M 30.98 M 0.00 335,000.00 395,000.00
    Total Liabilities 277.16 M 286.04 M 339.86 M 307.92 M 312.95 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 404.63 M 437.76 M 421.01 M 377.19 M 413.59 M
    Common Stock 374,000.00 364,000.00 359,000.00 351,000.00 348,000.00
    Capital Surplus 289.67 M 274.96 M 254.01 M 217.40 M 192.23 M
    Revaluation Reserves 0.00 0.00 0.00 — —
    Other Appropriated Reserves 0.00 0.00 0.00 -1.90 M -689,000.00
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings 182.43 M 230.20 M 200.26 M 193.52 M 253.73 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 — —
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 — —
    Unrealized Gain (Loss) on Marketable Securities 122,000.00 -1.36 M -431,000.00 0.00 0.00
    Treasury Stock 67.96 M 66.40 M 33.19 M 32.18 M 32.03 M
    Total Liabilities & Shareholders Equity 681.79 M 723.79 M 760.87 M 685.11 M 724.23 M
    Common Shares Outstanding 34.68 M 33.86 M 35.01 M 34.27 M 33.92 M